variance in transcripts on average, whereas single trans eQTLs only explain 0.02-0.07. The top cis eQTLs tend to explain more variance in the corresponding gene when its h 2 geneExp is greater. Taking body mass index (BMI) as a case study, we cross-linked cis/trans eQTLs with both GWAS SNPs and differentially expressed genes for BMI. We discovered that BMI GWAS SNPs in 16p11.2 (e.g., rs7359397) are associated with several BMI differentially expressed genes in a cis manner (e.g. SULT1A1, SPNS1, and TUFM). These BMI signature genes explain a much larger proportion of variance in BMI than do the GWAS SNPs. Our results shed light on the impact of eQTLs on the heritability of the human whole blood transcriptome and its relations to phenotype differences.
disease traits, such as coronary heart disease (Lotta and Peyvandi 2011; Schunkert et al. 2011 ), blood pressure (Ehret et al. 2011 Levy et al. 2009; Newton-Cheh et al. 2009 ), lipids , body mass index (Guo et al. 2013; Monda et al. 2013; Speliotes et al. 2010) , and type 2 diabetes (Morris et al. 2012; Voight et al. 2010) . Although GWAS have provided valuable insights into the genetic basis of complex traits, they explain only a small proportion of the heritability of most traits (Tenesa and Haley 2013) . For the majority of loci from GWAS, the mechanistic underpinnings for association with the corresponding traits are unknown. Gene expression may mediate genotype-phenotype association, and as such may be considered an intermediate molecular phenotype (Cheung and Spielman 2009) . Dissecting the genetic determinants of gene expression can provide insight into mechanisms of disease and the functional consequences of genetic variation. Genome-wide expression quantitative trait locus (eQTL) mapping has been widely used to identify common genetic variants regulating gene expression (Myers et al. 2007; Schadt et al. 2008; Stranger et al. 2005 Stranger et al. , 2007 Zeller et al. 2010) . Although numerous studies (Myers et al. 2007; Schadt et al. 2008; Stranger et al. 2005 Stranger et al. , 2007 Westra et al. 2013; Zeller et al. 2010 ) have revealed tens of thousands of cis and trans eQTLs, many cis and trans eQTLs remain unrecognized due to sample size limitations and tissue specificity (Grundberg et al. 2012; Price et al. 2011) . Further investigations are needed to answer additional questions, such as, are these cis or trans components related to the heritability of gene expression? and what is the proportion of variance in gene expression that can be explained by single cis or trans eQTLs?
In this study, we systematically investigated the heritability of the human whole blood transcriptome using Framingham Heart Study (FHS) pedigrees. Our goals were threefold. First, we explored the distribution of heritability of genome-wide gene expression levels using a large sample with well-defined extended pedigrees. Second, we investigated how cis and trans eQTLs are related to transcript heritability levels. Third, we sought to understand how the genetic basis of gene expression relates to phenotype differences and disease susceptibility via cis and trans components. To accomplish these aims, we estimated the overall heritability of approximately 18,000 genes in 5,626 participants from the FHS, and assessed the proportion of variance in gene expression that is attributable to cis and trans eQTLs. By cross-linking the eQTLs with GWAS results of metabolic traits including body mass index (BMI), blood pressure (BP), and lipid traits in the NHGRI GWAS Catalog (Hindorff et al. 2009 ), we discovered trait-associated single-nucleotide polymorphisms (SNPs) that explain relatively large proportions of the genetic variance of multiple gene transcripts, despite the fact that these SNPs only explain a small proportion of phenotypic variance for the same metabolic traits. Last, taking BMI as an example, by cross-linking the eQTLs with trait-associated SNPs [GWAS SNPs (Hindorff et al. 2009 )], we discovered that some GWAS SNPs are cis eQTLs of certain gene transcripts and can explain large proportions of variance in expression of these transcripts. In addition, some of the corresponding cis eQTL gene transcripts show differential expression for BMI. Although the GWAS SNPs only explain a small proportion of phenotypic variance in BMI, these differentially expressed cis eQTL-related gene transcripts explain a larger proportion of variance in BMI.
Materials and methods

Study population description
In 1971, the offspring and offspring spouses (offspring cohort, N = 5,124) of the original FHS cohort participants were recruited and have been examined approximately every 4 years (except for the interval between examinations 1 and 2 with an intervening 8 years) (Feinleib et al. 1975) . From 2002 to 2005, the adult children (third generation cohort, N = 4,095) of the offspring cohort participants were recruited and examined (Splansky et al. 2007) . A total of 5,626 participants from the offspring (N = 2,446) and third-generation (N = 3,180) cohorts were included in this study. Whole blood samples were collected at the eighth examination of the offspring cohort and the second examination of the third-generation cohort. All participants provided written consent for genetic research.
Gene expression profiling
Fasting peripheral whole blood samples (2.5 ml) in PAXgene™ tubes (PreAnalytiX, Hombrechtikon, Switzerland) were collected and the Affymetrix Human Exon Array ST 1.0 (Affymetrix, Inc., Santa Clara, CA) was utilized to measure mRNA expression levels genome wide (N = ~18,000 genes). Details of the design, sampling, RNA isolation, and mRNA measurement have been described previously Joehanes et al. 2013) . All data used herein are available online in dbGaP (http://www. ncbi.nlm.nih.gov/gap; accession number phs000007).
Genotyping and quality control DNA isolation, and genotyping with the Affymetrix 500K mapping array and the Affymetrix 50K gene-focused MIP array have been described previously (Levy et al. 2009 ). A total of 503,551 SNPs with successful call rate >0.95 and HardyWeinberg equilibrium (HWE) p > 10-6 were retained. Imputation of ~36.3 million SNPs in 1000 Genomes Phase 1 SNP data was conducted using MACH . In this study, we used the 1000-genome resource imputed SNPs with minor allele frequency (MAF) >0.01 and imputation ratio >0.3, yielding approximately 8 million SNPs for eQTL analysis.
eQTL identification
The eQTL list was generated using the 5,257 individuals that had genome-wide genotypes and gene expression profiling. A cis eQTL was defined as an eQTL within a 1 megabase (Mb) flanking the gene. A trans eQTL was defined as an eQTLs in a different chromosome from the gene. The remaining eQTLs residing in the same chromosome but extending 1 Mb distance were defined as longrange cis eQTLs. The imputed SNPs were coded in an additive genetic model of allele dosage that was continuous and ranged from 0 to 2. Linear mixed effects (LME) regression models were used to determine the association between gene expression (adjusting for age, sex, 10 technical covariates, cell types, the first principle component [PC1] , and familial relatedness) and the imputed SNP dosage from the 1000-Genomes resource (Abecasis et al. 2012 ). Supplementary Table S1 shows the 10 technical covariates and PC1. Cell types included white blood cells [WBC] , red blood cells [RBC] , platelets, neutrophils, lymphocytes, monocytes, eosinophils, and basophils, which were imputed by partial least squares (PLS) regression (Joehanes R, PhD, unpublished data) . Genomic coordinates were based on NCBI human reference genome build 37/ hg19. The Benjamini-Hochberg method (BH) (Benjamini and Hochberg 1995) was used to calculate false discovery rates (FDR) of cis, trans, and long-range cis eQTLs separately.
We evaluated if the effect sizes of cis and trans eQTLs in independent individual sets showed concordance of allele effect. We split the overall samples into the discovery and replication sets (1:1 ratio) that included independent families between the two sets. Using the same methods described above, we identified eQTLs in the discovery and replication sets, respectively, and compared the effect sizes of eQTLs from the discovery and replication set.
To determine if differences in cell type distributions in different samples affected the identification of cis and trans eQTLs, we applied regression models without including cell types as covariates to repeat the eQTL analysis for the cis and trans eQTLs at FDR <1e−4. We then compared the t test statistics of cis and trans eQTLs with and without adjusting for cell types.
By design, the Affymetrix Human Exon 1.0 ST array platform contains SNPs in some probes for targeting mRNA sequence; this SNP-on-probe phenomenon can affect the binding affinity of microarray probe sequences and may lead to false-positive and false-negative results (Ramasamy et al. 2013 Heritability estimation for all gene expression traits was performed using the combined sample (N = 5,626). To determine whether heritability estimates were consistent in individual cohorts, we conducted analysis in the offspring cohort (N = 2,446) and the third-generation cohort (N = 3,180) separately. The average heritability estimate was calculated as n 1 h 2 geneExp /n, where n = number of gene expression traits.
We further investigated if the heritability estimates in relation to cohorts, sample size and blood cell type portions (see Supplementary Files).
The proportion of variance in gene expression attributable to peak eQTLs The proportion of variance in a single gene expression trait that is attributable to a single eQTL (or eSNP) was denoted as h 2 eQTL and was calculated as follows:
where σ 2 geneExp was the total phenotypic variance of a gene expression trait; σ 2 QTL.full and σ 2 err.full were the polygenic variance and the residual error, respectively, when modeling with the tested eQTL; σ 2 QTL.null and σ 2 err.null were the polygenic variance and the residual error when modeling without the tested eQTL. The relative proportion of variance explained by a peak eQTL with respect to the (Hindorff et al. 2009 ). We used a p value ≤5e−8 to define a traitspecific significant result.
Identification of differentially expressed genes for BMI
To determine the proportion of variance that can be explained by differentially expressed genes or by eQTLs of these differentially expressed genes for a clinical trait, we used BMI as an example for proof-of-concept. We identified differentially expressed genes for BMI which was measured at the same examinations of the offspring and the third-generation cohorts at which gene expression was assessed. Residuals for genes (after adjusting for technical covariates) were used to identify differentially expressed genes associated with BMI after accounting for age, sex, and family structure in LME models implemented in lmekin() (Abecasis et al. 2001 ). We applied Benjamini-Hochberg's FDR <0.05 to denote significant signals and calculated FDR for selected BMI signature genes (Benjamini and Hochberg 1995) . The proportion of the variance in BMI attributable to multiple differentially expressed signature genes was calculated using Eq. (2).
(2)
Results
Study participants Table 1 summarizes the characteristics of the 5,626 FHS participants used in this study. At the baseline examination, the offspring cohort is, on average ~20 years older than the third-generation cohort (66 vs. 46 years). Supplementary  Table S2 
Heritability estimation of genome-wide gene expression measurements
The narrow sense heritability of ~18,000 transcripts was estimated using the FHS pedigrees. For simplicity, we refer to "narrow sense heritability" as "heritability" in the rest of this manuscript. Figure 1 displays the distribution of heritability estimates for 18,000 genes based on all 5,626 participants [Supplementary Figure S1 displays the results for 6,059 genes without SNPs-on-probes (see "Materials and methods)"]. The average heritability of global gene expression was estimated to be 0.072 (the median heritability estimate was 0.037). Among all genes, 7,161 (~40 % of the genome) were estimated to have h 2 geneExp > 0 (p < 0.05), 1,730 (~10 %) with h 2 geneExp > 0.2 (p < 1.8e−6), 286 (~2 %) with h 2 geneExp > 0.4 (p < 6.3e−41), and 50 (~0.3 %) with h 2 geneExp > 0.6 (p < 3.7e−105). We further investigated if the heritability estimates differed in relation to cohort (offspring vs. third generation), sample size, and blood cell type portions. We discovered that the overall heritability distribution is similar in the FHS offspring and third-generation cohorts. In addition, differences in cell type proportions are not likely to significantly affect the heritability of gene expression levels. We also discovered that larger sample size and more comprehensive family structure provide more accurate heritability estimates (see Supplementary Files, Supplementary Figure  S2 -S3, and Supplementary Table S3 ).
Effects of cis and trans eQTLs on gene expression
We performed a genome-wide association analysis of global gene expression levels and identified cis, trans and long-range cis eQTLs. The proportion of gene transcripts with significant cis, trans and long-range cis eQTLs is much smaller at h 2 geneExp < 0.2 than at h 2 geneExp > 0.2. At FDR, <1e−4; 43 % of genes have cis eQTLs at h 2 geneExp < 0.2, compared to 93 % of genes at h 2 geneExp > 0.2. Similarly, 3 % of genes have trans eQTLs at h 2 geneExp < 0.2, compared to 21 % of genes at h 2 geneExp > 0.2; and 1 % of genes have long-range cis eQTLs at h 2 geneExp < 0.2, compared to 10 % of genes at h 2 geneExp > 0.2. We further computed the proportion of variance explained by a single cis or trans eQTL (h 2 eQTL ) in the study samples for genes with expression heritability levels h 2 geneExp > 0.2 (1,730 genes or 10 % of the total gene expression traits). By splitting the overall samples into independent discovery and replication sets (see "Materials and methods"), we discovered that cis and trans eQTLs show consistent allelic directional associations both in the discovery and replication sets (Supplementary Figure  S4) . We evaluated if cell types affected the identification of eQTLs. The t test statistics remained very similar with or without adjusting for cell types for both cis (Pearson r = 0.99) and trans (Pearson r = 0.98) eQTLs, suggesting that the differences of cell type distributions in different samples did not have large impact on the identification of either cis or trans eQTLs (Supplementary Figure S5) . A similar finding was also reported by Westra et al. (2013) in a trans eQTL study.
We further applied a series of FDR thresholds (FDR <1e−4, 1e−6, 1e−8 and 1e−10) to select significant eQTLs. Figure 2 summarizes the proportions of gene transcripts with significant cis, trans or long-range cis eQTLs at different h 2 geneExp levels = (0.2, 0.3), (0.3, 0.4), (0.4, 0.5) and (0.5, 0.6). We observed that gene expression traits with higher heritability estimates tend to have higher proportions of significant cis eQTLs. For example, at FDR <1e−4 (corresponding p = 3.2e−6), 49 of the 50 genes at h 2 geneExp of (0.6, 1) are associated with cis eQTLs. For the other four heritability categories, i.e., h 2 geneExp = (0.2, 0.3), (0.3, 0.4), (0.4, 0.5), and (0.5, 0.6), the proportions of genes with cis eQTLs are 92, 91, 96, and 100 %, respectively (Fig. 2a) . Compared to the proportions of significant cis eQTLs, in general, the proportions of significant trans eQTL are much smaller across all heritability categories. The transcripts of trans eQTLs are associated with heritability values in an opposite manner. For FDR thresholds, gene expression traits with higher heritability estimates tend to have lower proportions of significant trans eQTLs (Fig. 2b) . For example, at FDR threshold <1e−4 (corresponding p = 1.6e−10), the proportions of trans eQTLs genes are 22, 24, 16, 16, and 2 %, respectively, for the 5 heritability categories. The long-range cis eQTLs exhibit characteristics similar to those cis eQTLs rather than trans eQTLs (Fig. 2c) . For all FDR thresholds, gene expression traits with higher heritability estimates tend to have higher proportions of significant long-range cis eQTLs.
Through investigating the peak cis, trans, or long-range cis eQTL for every gene, we discovered that the peak cis eQTLs explain a large proportion of variance in their respective gene expression level (Supplementary Table S4 and Fig. 3a) . On average, the proportion of variance in the transcript with h 2 geneExp > 0.2 explained by a peak cis eQTL is about one-third. Moreover, when the heritability of gene expression increases from h 2 geneExp of (0.2, 0.3) to (0.6, 1), the average h 2 cis−eQTL increases from 0.33 to 0.53 (Fig. 3a) . Table S5 and Fig. 3b) . For long-range cis eQTLs, when the heritability of gene expression increases from h 2 geneExp of (0.2, 0.3) to (0.6, 1), the average h 2 long−cis−eQTL increases from 0.07 to 0.18 (Supplementary Table S6 and Fig. 3c) .
To avoid the SNP-on-probe effect that may lead falsepositive and false-negative results, we repeated analyses limited to 6,059 gene transcripts without any SNPs-onprobes (see "Materials and methods"). Supplementary Figures S6-S7 present results for these 6,059 genes. The results are similar for these 6,059 genes vs. all 18,000 genes (Figs. 2, 3 ).
GWAS SNPs of metabolic traits explained a large proportion of variability in eQTL genes
We cross-linked the GWAS results for several metabolic traits with the cis and trans eQTLs for genes with h 2 geneExp > 0.2 (the threshold for choosing eQTLs is FDR <1e−3). Table 2 summarizes a list of cis eQTLs that explain relatively large proportions of heritability in the corresponding gene expression levels (rh 2 eQTL ≥ 0.1). These cis eQTLs are among the peak signals for the corresponding genes (eQTL p < 1e−40). Although these significant GWAS SNPs (that also are cis eQTLs) explain only very small proportions (rh 2 trait_SNP ≤ 0.001) of genetic variance in the metabolic traits with which they are associated, these SNPs (cis eQTLs) explain relatively large proportions of the genetic variance in gene expression levels, and more strikingly, several cis eQTLs display large rh 2 eQTL estimates (>0.5). Although some cis eQTLs display higher values of rh 2 eQTL for a transcript, the transcript does not necessarily correspond to the closest gene to the cis eQTL. For example, rs486416 [associated with total cholesterol and triglycerides in GWAS ] is located in the intron of EHMT2, but this SNP is associated with expression of SLC44A4 in a cis manner with rh 2 eQTL = 0.87 for the SLC44A4 transcript. Additionally, we discovered that some cis eQTLs are associated with multiple gene expression traits and display relatively high rh 2 eQTL . For example, rs12936231 [associated with HDL in GWAS ] is a cis eSNP of both GSDMB (rh 2 eQTL = 0.92, 28 KB away from rs12936231) and ORMDL3 (rh 2 eQTL = 0.34, 48 KB away from rs12936231) (Fig. 4a) . Fig. 2 Relationship between heritability estimates and proportion of genes with cis, trans or long-range cis eQTLs. a Proportion of transcripts having cis eQTLs in different heritability levels; b proportion of transcripts having trans eQTLs in different heritability levels; c proportion of transcripts having long-range cis eQTLs in different heritability levels ◂ Table 3 summarizes trans eQTLs for genes with h 2 geneExp > 0.2. In contrast to cis eQTLs, most trans eQTLs display smaller rh 2 eQTL (≤0.1) with only one exception trans eQTL rs289754 for BTN3A1 (rh 2 eQTL = 0.19). Although having smaller average rh 2 eQTL , some trans eQTLs are also associated with multiple gene transcripts. Table 3 displays two such trans eSNPs: one example is rs3184504, which is nonsynonymous in SH2B3 and is associated in GWAS with SBP, DBP (Levy et al. 2009 ) and LDL . rs3184504 is a trans eQTL associated with five gene transcripts including FCGR1A (rh 2 eQTL = 0.04), ARHGEF40 (rh 2 eQTL = 0.03), MYADM (rh 2 eQTL = 0.03), IDO1 (rh 2 eQTL = 0.02) and IFIT3 (rh 2 eQTL = 0.02). Another SNP, rs289754, is a trans eSNP associated with three genes located in the MHC Cluster I-BTN3A1(rh 2 eQTL = 0.19), HCP5 (rh 2 eQTL = 0.10) and HLA-F (rh 2 eQTL = 0.04) (Fig. 4b) .
Identification of "master" eQTLs associated with BMI signatures genes Based on our finding that some eQTLs explain large proportions of variation in gene expression levels (h 2 eQTL )-although they only explain small proportions of variance in metabolic traits-we investigated the relations between the trait-specific differential expression signature genes and the genes with the eQTLs that also are GWAS SNPs for the same trait. Using BMI as a proofof-concept example, at first, we identified BMI differentially expressed genes at FDR <0.05 (i.e., BMI signature genes, Supplementary Table S7) . Second, we cross-linked these signature genes with significant BMI GWAS SNPs as well as with eQTLs. By doing so, we discovered that 9 BMI signature genes are associated with 6 BMI GWAS SNPs (Speliotes et al. 2010 ) in a cis manner (Table 4) . Among a total of 18,000 genes measured by the Affymetrix Exon Array, 18 genes had cis eQTLs with p < 5e−8 in BMI GWAS. Comparison of the two ratios 9/5,409 and 18/18,000 by hypergeometric test yielded p = 0.02, indicating the BMI transcriptomic signatures were enriched for BMI GWAS SNPassociated transcripts at p = 0.02 by hypergeometric test. rs7359397 is a cis eQTL for three BMI signature genes-SULT1A1 (FDR adjusted p = 0.05), SPNS1 (FDR adjusted p = 5.6e−4), and TUFM (FDR adjusted p = 0.03). Other two genes located near rs7359397, CD19 and SH2B1, also are BMI signature genes at FDR adjusted p = 0.04 and 1e−4, however, rs7359397 was not recognized as a cis eQTL for these two genes Fig. 3 Proportion of transcript variance explained by peak eQTLs. a Variance proportion of a transcript explained by a single peak cis eQTL; b variance proportion of a transcript explained by a single peak trans eQTL; c variance proportion of a transcript explained by a single peak long-range cis eQTL ◂ (Fig. 5a, b) . We further discovered groups of differentially expressed genes that are associated with the same GWAS SNPs and jointly explain greater proportions of the variance in BMI than do the SNPs associated with the trait in GWAS. For instance, rs7359397 only explained 0.0086 % of phenotypic variance in BMI (calculated using FHS data alone), but the three BMI signature genes (SULT1A1, SPNS1, and TUFM) that are associated with this SNP in cis manner, jointly explained 0.5 % of the interindividual variability in BMI (Fig. 5c ).
Discussion
We systematically investigated the heritability of global gene expression using whole blood samples from 5,626 FHS participants. To our knowledge, this is the largest heritability study of global gene expression. We observed that approximately 40 % of the genome (7,161 gene) display h 2 geneExp > 0 and ~10 % displayed h 2 geneExp > 0.2. We confirmed that transcripts with higher heritability estimates are more likely to be associated with cis eQTLs, but this is not Dixon et al. 2007; Goring et al. 2007; Grundberg et al. 2012) . Moreover, we found that single cis eQTLs explain on average 0.33-0.53 of variance in expression levels for genes with h 2 geneExp > 0.2. Single trans eQTLs, however, only explain 0.02-0.07 of variance in transcripts with h 2 geneExp > 0.2. Interestingly, we discovered that the top cis eQTLs tend to explain more variance in the respective transcript when h 2 geneExp increased, but there is no obvious trend for the top trans eQTLs. Taking BMI as a case study, by cross-linking the cis/trans eQTLs with BMI GWAS SNPs (Hindorff et al. 2009; Speliotes et al. 2010) and BMI signature genes, we observed that some BMI GWAS SNPs are actually the cis eQTLs for multiple BMI signature genes. Although these SNPs (also cis eQTLs) explain only very small proportions of variance in BMI, they explain relatively larger proportions of variance in gene expression levels. These BMI signature genes-driven by the BMI GWAS SNPs-jointly explain a larger proportion of the variability in BMI than do the GWAS SNPs.
We found that 40 % of gene transcript levels are heritable and the average heritability of global gene expression genome wide is estimated to be 0.07 (for all 18,000 genes) and 0.13 (for 7,161 genes with h 2 geneExp > 0). Several studies reported that 40-70 % of gene transcripts are heritable with h 2 geneExp > 0 (Emilsson et al. 2008; Goring et al. 2007; Price et al. 2011; Stranger et al. 2007) . Dixon et al. (2007) reported that the average heritability for global gene expression is 0.2, and the average heritability for transcripts with h 2 geneExp > 0 ranges between 0.15 and 0.30 (Emilsson et al. 2008; Price et al. 2011; Stranger et al. 2007 ). These heritability estimates are considerably larger than our findings. By sub-sampling FHS families, we discovered that Figures S3) than large and complex family structures, which may partly explain the different heritability estimates reported in several previous studies and in our sample. Heritability is the proportion of phenotypic variation attributable to genetic variation; varying levels of pedigree structures are needed to obtain accurate variance parameters from genetic and environmental components to get more accurate estimation of heritability. The current study sample (N = 5,626) that consists of extended families of two generations of FHS participants is five times larger than the sample sizes of prior studies (Emilsson et al. 2008; Goring et al. 2007; Price et al. 2011; Stranger et al. 2007 ). In addition, the heritability estimates are further compared between the offspring cohort (N = 2,446) and the thirdgeneration cohort (N = 3,180) , and between samples with higher vs. lower WBC, neutrophil, or lymphocyte proportions. With a large sample size, complex family structure, and careful study design, we believe that the heritability estimates of global gene expression in the current study are more stable and reliable than previous findings.
In this study, we confirmed that cis components explain a larger proportion of variance in expression levels of genes than trans components (Grundberg et al. 2012; Price et al. 2011 ). In addition, we discovered that the proportion of genetic variance in a transcript explained by the peak eQTL is different for transcripts with different heritability estimates. On average, approximately 53 % (rh 2 eQTL = 0.53) of genetic variance for transcripts with h 2 geneExp > 0.6 is explained by a single cis eQTL, and the proportion decrease to 33 % (rh 2 eQTL = 0.33) for transcripts with h 2 geneExp = 0.2-0.3. This finding suggests that, in general, transcripts with higher heritability estimates are affected by fewer nearby genetic loci compared to transcripts with lower heritability. In contrast, the most significant trans eQTLs explain, on average, much smaller proportions of genetic variance in transcripts and do not show obvious trends in relation to heritability estimates (h 2 eSNP ranges from 0.02 to 0.07 for transcripts on average in all h 2 geneExp levels). Grundberg et al. (2012) estimated that at least 0.12 of total heritability of transcripts is "missed" when only considering common cis eQTL effects, and they proposed that the "missing heritability" might be due to low-frequency and rare variants. However, our findings suggest that the "missing heritability" may also be attributable in part to trans eQTLs with modest genetic effects that are not detected easily in smaller-sized eQTL studies.
By cross-linking GWAS results for metabolic traits with transcripts and with cis and trans eQTLs, we identified a number of GWAS SNPs that explain large proportions of the variation in several genes (Tables 2, 3 ). For example, rs12936231, a cis eQTL for GSDMB, explains up to 92 % of genetic variance in GSDMB. We also discovered that some GWAS SNPs, that we consider to represent master eQTLs, are associated with multiple transcripts. For example, rs3184504 is a trans eQTL for 5 genes, FCGR1A, ARHGEF40, MYADM, IDO1, and IFIT3. The mechanism underlying the associations of multiple transcripts with a single eQTL (a master eSNP) has not been elucidated (Pruim et al. 2010) ] of BMI GWAS SNPs (peak SNP rs7359397) and its proxy genes. The y-axis is −log10-transformed BMI GWAS p values from GIANT (Speliotes et al. 2010) ; the genes marked by rectangle indicating eQTL genes and BMI signature genes. (The genes marked by green rectangle indicating eQTL genes, by blue rectangle indicating BMI signature genes, and by red rectangle indicating the overlap of eQTL genes and BMI signature genes, as shown in online color figures.) b Schematic figure depicting BMI GWAS SNP (peak SNP rs7359397) is associated with multiple genes in cis-manner, and some of those genes are differentially expressed for BMI; c rs7359397 driving BMI differential gene expression signatures. The number above the directed curved line indicated the phenotypic proportion of transcripts explained by the SNP, the phenotypic proportion of traits explained by the SNP, or the phenotypic proportion of traits explained by trait signatures to date. One possible mechanism is that transcripts sharing common cis/trans eQTLs may be tightly co-expressed and involved in the same biological process or pathway (Rotival et al. 2011) . Another possible explanation is that the cis/trans eQTL and its proxy SNPs may have an effect on a regulatory component, such as transcription factors (TFs) or microRNAs (miRNAs) that regulate multiple transcripts, and this eQTL is thereby associated with multiple transcripts targeted by the TFs or the miRNAs. Figure 4b illustrates a "master" effect by a trans eQTL that is located in or near a TF or a key regulator. Different alleles of the trans eQTL may affect the transcription or translation of the TF or key regulator, giving rise to different isoforms of the TF or key regulation. Multiple genes whose expression levels are regulated by those TFs or key regulators may show association with this SNP. For example, rs289754 is located in the intron of NLRC5 (16q13) and is a trans eQTL for three genes: BTN3A1 (6p22), HCP5 (6p21.3) and HLA-F (6p21.3). Rs289754 explained 0.19, 0.10, and 0.04 of the heritability of BTN3A1, HCP5 and HLA-F, respectively (Table 4) . NLRC5 has been newly recognized as a key regulator of MHC class I-related immune functions (Kobayashi and van den Elsen 2012) . However, NLRC5 itself does not have a DNA-binding domain and must interact with multiple proteins to activate the MHC class I-dependent immune response (Kobayashi and van den Elsen 2012) . The third possible explanation is that the common cis eQTLs in the nearby region display allelic effects on the nucleosome, chromatin structure, or TF binding affinity, and in this way govern the transcriptional activity of nearby genes. Figure 4a shows a mechanism by which a "master" cis eQTL affects transcription of multiple nearby genes. Supportive evidence exists for rs12936231 (17q21), which displays CTCF promoter binding in eight cell lines (Verlaan et al. 2009 ). CTCF is a well-characterized protein involved in chromatin looping and chromosome repositioning. The same study (Verlaan et al. 2009 ) reported that rs12936231 is a significant cis eQTL for GSDMB [distance ~28 KB from transcription start site (TSS)] and ORMDL3 (distance ~48 KB from TSS) gene expression. We were able to confirm that rs12936231 is significantly associated with transcripts from the nearby genes GSDMB (p value = 0) and ORMDL3 (p value = 1.34e−92). In addition, we discovered that rs12936231 explains 0.94 of heritability of GSDMB and 0.34 of the heritability of ORMDL3 expression levels (Table 3) , thereby providing further evidence that rs12936231 regulates both genes. However, a functional study is needed to further elucidate the role of the eQTL in relation to gene regulation. We further linked the trait-GWAS SNPs and trait-signature genes via their eQTLs. Taking BMI as proof-of-concept case study, we found several BMI signature genes that are associated with BMI GWAS SNPs in a cis manner. For example, BMI GWAS SNP rs7359397 (p = 1.64e−14 in BMI GWAS (Speliotes et al. 2010) ) is a cis eQTL for 3 BMI signature genes (SULT1A1, SPNS1, and TUFM, Fig. 4 ; Table 4 ) among its six cis eQTL genes. These three BMI signature genes extend the proportion of phenotypic variance of BMI explained by rs7359397.
Conclusions
We systematically evaluated the heritability of global whole blood gene expression using a large sample size of FHS extended pedigrees. We discovered that with increasing heritability of transcripts, there is an increase in the contribution of cis, but not trans regulation. Future studies are needed to investigate if this finding holds true across different tissues. By cross-linking the eQTLs with trait-associated SNPs [i.e., BMI GWAS SNPs (Hindorff et al. 2009 )], we discovered that some GWAS SNPs are cis eQTLs of certain gene transcripts and can explain large proportions of variance in expression of these transcripts. In addition, some of the corresponding cis eQTL gene transcripts show differential expression in relation to the same trait (i.e., BMI). Although the GWAS SNPs only explain a small proportion of phenotypic variance in BMI, the differentially expressed cis eQTL-related gene transcripts explained a larger proportion of variance in BMI. Overall, our results shed light on the impact of eQTLs on the heritability of the human blood transcriptome, and the role of eQTLs in promoting phenotype differences and disease susceptibility.
